Live Breaking News & Updates on Alvogen Teriparitide

Ligand Pharmaceuticals Inc (LGND) Q1 2021 Earnings Call Transcript
Motley Fool Transcribers
© The Motley Fool
Logo of jester cap with thought bubble.
Ligand Pharmaceuticals Inc (NASDAQ: LGND)
Popular Searches
Operator
Good afternoon, and thank you for standing by. Welcome to the Ligand Pharmaceuticals Quarter One Earnings Call. [Operator Instructions]. After the speakers presentation, there will be a question-and-answer session. [Operator Instructions]. I would now like to hand the conference over to your speaker today, Mr. Simon Latimer. Sir, the floor is yours.SPONSORED:
10 stocks we like better than Ligand Pharmaceuticals
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, ....

United States , Menlo Park , Matt Hewitt , Joseph Pantginis , Dana Flanders Guggenheim , Simon Latimer , Matt Korenberg , Matt Foehr , Balaji Prasad Barclays , John Higgins , Balaji Prasad , Jacob Johnson , Larry Solow , Alvogen Teriparitide , Scott Henry Roth , Scott Henry , Dana Flanders , Craig Hallum , Ligand Pharmaceuticals Inc , Our Pelican Expression Technology , Pelican Expression Technology , Serum Institute , Motley Fool Ligand Pharmaceuticals Inc , Cstone Pharmaceuticals , Simon Latimer Corporate Development , Ligand Pharmaceuticals ,